Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06492733 · ClinicalTrials.gov registry record · NA
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
A NA study of Chronic Total Occlusion of Artery of the Extremities, sponsored by Versono Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 6
- Study locations
NCT06492733: Recruiting NA study of Chronic Total Occlusion of Artery of the Extremities, sponsored by Versono Medical.
NCT06492733 is a NA study of Chronic Total Occlusion of Artery of the Extremities that is actively recruiting participants, run by Versono Medical. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06492733, a NA study of Chronic Total Occlusion of Artery of the Extremities, is actively recruiting participants, sponsored by Versono Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is to assess the safety and efficacy of the FastWire System. It is intended to assess that the FastWire System can facilitate the intra-luminal placement of conventional guidewires or treatment devices beyond peripheral artery chronic total occlusions (CTOs)
Primary Outcome
Ability to facilitate treatment of the target lesion using the FastWire as a crossing device only and by allowing additional devices to cross the CTO as required. This will be angiographically confirmed.
Conditions Studied
Interventions
- DEVICE FastWire System - Peripheral
Study Locations (6)
Delaware
- EndoVascular Consultants - Wilmington
Florida
- Vascular & Embolization Specialists - Cocoa
Iowa
- Vascular Institute of the Midwest - Davenport
Louisiana
- Cardiovascular Institute of the South-ASC - Gray
Michigan
- Dearborn Cardiology - Dearborn
Tennessee
- Vascular Institute of Chattanooga - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT06492733 shows while recruiting
NCT06492733 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Chronic Total Occlusion of Artery of the Extremities appearing as the primary indexed condition, and to 1 intervention - of which FastWire System - Peripheral is the first listed.
NCT06492733 lists 6 locations in 6 states (Delaware, Florida, Iowa).
Frequently Asked Questions
What is clinical trial NCT06492733 about?
NCT06492733 is a clinical study titled "FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW". This study is to assess the safety and efficacy of the FastWire System. It is intended to assess that the FastWire System can facilitate the intra-luminal placement of conventional guidewires or treatment devices beyond peripheral artery chronic total occlusions (CTOs)
What is the current status of trial NCT06492733?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2024-11-05. Estimated completion is 2026-07.
What conditions does trial NCT06492733 study?
This clinical trial studies the following conditions: Chronic Total Occlusion of Artery of the Extremities.
What interventions are being tested in trial NCT06492733?
The interventions under investigation include: FastWire System - Peripheral (DEVICE).
Who is sponsoring clinical trial NCT06492733?
This trial is sponsored by Versono Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06492733 being conducted?
This trial has 6 study locations across Delaware, Florida, Iowa, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Total Occlusion of Artery of the Extremities
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06492733's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI